Valens GroWorks Corp (CSE:VGW, OTC:VGWCF) has released its fifteenth episode of Extracted which covered the benefits and challenges of organic cultivation with The Green Organic Dutchman (TGOD) (TSX:TGOD) VP of Growing Operations David Bernard-Perron. Bernard-Perron was formerly the Agrologist at Whistler Medical Marijuana Corporation, and he holds a Masters in Plant Sciences from McGill University. TGOD is helping Valens achieve its organic certification so the company can deliver high-end organic extracted products.

TGOD is certified organic under Pro-Cert, one of North America’s most-regarded organic certification bodies, and has certifications from EcoCert Canada and LEED as well. According to Bernard-Perron, being organically certified adds layers of complexity as the company needs to be compliant with several additional standards. However, the critical difference between a conventional growing operation and an organic one is adhering to a permitted substances list which includes no chemically modified inputs. TGOD uses a “living soil” and a “natural soil food web” to create a sustainable, beneficial system for growth.

By growing organically, TGOD can build a reserve of nutrients and create a web of beneficial bacteria, fungi, insects and micro and macro organisms that continuously deliver nutrients to the plants. This allows the plants to build its immune system and defense mechanisms, which in turn, produces more terpenes, THC, CBD and secondary metabolites.

“Organic, living soil, sun-grown cannabis really helps to maximize the genetic potential of the plants,” said Bernard-Perron.

Looking to the future, Bernard-Perron believes that there will be a demand for organic flower, likening it to the shortage in the organic food market. On the medical side of things, he believes that there will always be people looking for a natural alternative.

To listen to the full podcast, click here.

infoClick here to connect with Valens GroWorks Corp (CSE:VGW, OTC:VGWCF)  for an Investor Presentation. 

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less